Cell Impact AB (CI) Stock Statistics & Valuation Metrics

Cell Impact AB has a market cap or net worth of kr78.95M. The enterprise value is kr61.30M.

Cell Impact AB has 589,169,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cell Impact AB’s return on equity (ROE) is -1.09 and return on invested capital (ROIC) is -84.61%.

The current PE Ratio of Cell Impact AB is ―. Cell Impact AB’s PEG ratio is -0.00080.

In the last 12 months, Cell Impact AB had revenue of 5.57M and earned -131.98M in profits. Earnings per share was -0.65.

In the last 12 months, operating cash flow was -45.36M and capital expenditures -1.93M, giving a free cash flow of -47.29M billion.

Cell Impact AB pays an annual dividend of ―, resulting in a dividend yield of ―

Cell Impact AB upcoming earnings date is Feb 13, 2026, TBA (Confirmed).

Cell Impact AB as a current ratio of 2.02, with Debt / Equity ratio of 26.88%

In the past 12 months, Cell Impact AB has paid 5.00K in taxes.

Cell Impact AB EV to EBITDA ratio is -0.98, with an EV/FCF ratio of -1.14.

Cell Impact AB has kr10.86M in cash and marketable securities with kr32.54M in debt, giving a net cash position of -kr21.68M billion.

Gross margin is -2242.94%, with operating margin of -2242.94%, and net profit margin of -2369.55%.

The average price target for Cell Impact AB is ―, which is 11.43% higher than the current price. The consensus rating is ―